RNA is a promising reservoir of new drug targets. Here, the authors introduce RNAmigos2, a structure-based deep learning model that speeds up screening by 10,000x while rivaling docking accuracy, showing success in identifying RNA-binding compounds in vitro.
- Juan G. Carvajal-Patiño
- Vincent Mallet
- Jérôme Waldispühl